BioNTech SE Sponsored ADR

BNTX Healthcare Biotechnology

BioNTech SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 9.07% from fiscal 2024. In the quarter to June 2026, revenue fell 58.5%, EPS fell 107.1%, free cash flow fell 342.0% and total debt rose 20.1%, each against the same quarter a year earlier.

87.57 2.63 −2.92%
Market cap
$22.7B
P/E
0.0×
Fwd P/E
−17.4×
Dividend yield
—
F-score
4/9
Altman Z
n/a
Beneish M
−2.74
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
17,786.17 18,178.42 18,268.26 18,504.51
Total non-current assets
5,866.17 6,486.71 6,609.64 6,441.11
Total Assets
23,652.34 24,665.13 24,877.90 24,945.61
Total current liabilities
2,266.34 2,065.76 2,423.80 2,597.88
Total non-current liabilities
739.36 715.47 703.84 749.62
Total liabilities
3,005.70 2,781.22 3,127.64 3,347.50
Common Equity (Total)
20,646.64 21,883.91 21,750.26 21,598.12
Shareholders Equity (Total)
20,646.64 21,883.90 21,750.26 21,598.12
Total Debt
367.53 354.40 302.54 286.85

Show all line items

In millions of $ except per-share values · columns are period end dates